Eli Lilly Introduces Lormalzi For Early Alzheimer`s Treatment
15 May 2026 //
INDPHARMAPOST
FDA Approves Blood Cancer Drugs From Beone And Taiho
15 May 2026 //
REUTERS
Vyome Acquires Exclusive License For Selective JAK Inhibitor
15 May 2026 //
INDPHARMAPOST
Biogen`s Anti-Tau Drug Misses Phase 2, Shows Efficacy Signals
15 May 2026 //
BIOSPACE
Biotech leaders pitch Pazdur as next FDA chief
15 May 2026 //
BIOSPACE
Regenxbio Hits Duchenne Milestone, Eyes 2027 FDA Approval
15 May 2026 //
BIOSPACE
Astrazeneca Follows Merck With Phase 3 Win In Bladder Cancer
15 May 2026 //
ENDPOINTS
Biogen Completes Acquisition Of Apellis Pharmaceuticals
15 May 2026 //
GLOBENEWSWIRE
BMS Partners With Tempus To Enhance Clinical Success With AI
15 May 2026 //
FIRSTWORD PHARMA
Drugs In Development
Market Intel

Market Place
Sourcing Support